Introduction
Bis-(2-chloroethyl)sulfide, also known as sulfur mustard (SM*) or mustard gas, is acutely toxic to the skin, respiratory tract and eyes and causes a delayed bone marrow depression. In addition, SM is considered carcinogenic to humans by the IARC (1). Since all of these toxicities are apparently initiated by DNA alkylation, a knowledge of the DNA damage caused by this agent and the cellular defenses against this damage are of fundamental importance (2) .
SM-induced DNA modification occurs primarily at the N-7 position of guanine and the N-3 position of adenine with the formation of 7-hydroxyethylthioethyl guanine (7HETEG), 3-hydroxyethylthioethyl adenine (3HETEA), and the cross-link, di-(2-guanin-7-yl-ethyl)sulfide (3) (4) (5) . A search for the product, C^-hydroxyethylguanine, has been unavailing (4), although the analogous adduct, C^-ethylthioethylguanine, was identified in DNA that had been reacted with 2-chloroethylethyl sulfide (6) .
Perhaps because of difficulties in working with this highly toxic compound, relatively few biochemical investigations have been carried out on the repair of SM-induced DNA modifications. Early investigators did obtain evidence for the enzymatic removal of the adducts from the DNA of Escherichia coli exposed to low levels of SM (7) (8) (9) . Subsequently, other investigators have shown that adducts are also removed from the DNA of mammalian cells exposed to SM (10-12).
•Abbreviations: CEES, 2-chloroethyl ethyl sulfide; DMS, dimethyl sulfate; Gly n, glycosylase D; 3HETEA, 3-hydroxyethylthioethyl adenine; 7HETEG, 7-hydroxyethylthioethyl guanine; HPLC, high performance liquid chromatography; 3MA, 3-methyladenine; 7MG, 7-methylguanine; SM, sulfur mustard.
Papirmeister and his colleagues studied the cytotoxic and mutagenic effects of the monofunctional SM, 2-chloroethyl ethyl sulfide (CEES), on E.coli defective in certain DNA repair mechanisms (13) . These studies indicated that excision repair plays an important role in protecting E.coli from CEES toxicity.
Recently, we investigated the ability of bacterial glycosylases to release CEES-modified bases from DNA (14) . E.coli has two glycosylases: 3-methyladenine (3MA) DNA glycosylase I, which is constitutive, and 3MA DNA glycosylase II (Gly II), which is inducible. The latter enzyme has a wide substrate specificity and releases both 7-ethyltnioethyl guanine and 3-ethylthioethyl adenine from CEES-modified DNA.
When [
14 C]labeled SM became available to us, we decided to investigate the activity of Gly II towards DNA modified with this agent. Studies with chloroethylnitrosourea-modified DNA have shown that the nature of the alkyl substituent affects the ability of Gly II to release DNA adducts, and that 7-hydroxyethyl guanine is released very slowly in comparison with other 7-substituted guanines (15) . Thus, it was by no means certain that the hydroxyethylthioethyl adducts produced by SM would be released as readily as the ethylthioethyl adducts produced by CEES. However, the studies reported here indicate that Gly II has high activity towards the SMmodified bases, 7HETEG and 3HETEA. (16) . The high performance liquid chromatography (HPLC) markers, 7HETEG and 3HETEA, were obtained from the reaction of deoxyguanosine and adenine with 2-chloroethyl 2-hydroxyethyl sulfide as described previously (5) . Optical marker for the SM-induced cross-link, di-{2-guanin-7-yl-ethyl)sulfide, was kindly supplied by Dr H.P.Benschop (4) .
Materials and methods

Materials
]DMS-DNA were prepared by reacting the radiolabeled alkylating agents with DNA in 50 mM sodium cacodylate buffer, pH 7, as described previously (5, 17) . All operations involving SM were carried out in a special SterilchemGARD hood (Baker Company Inc., Sanford, ME) with bag in/bag out charcoal filters; personnel were protected with double vinyl gloves and laboratory coats. The alkylated DNAs were precipitated with alcohol, redissolved and reprecipitated until they reached constant specific activity. To determine the content and distribution of alkylated bases, [ 14 C]SM-DNA was depurinated by adjusting the pH to 3.5 with H3PO4 and incubating at 90°C for 1 h. [ 3 H]DMS-DNA was depurinated by overnight incubation in 0.1 N HC1 at 37°C. Optical markers were added and modified bases were collected and separated by HPLC; 1 min fractions were collected and counted in an LKB model 1214 liquid scintillation counter. Compositions of the two substrates are given in Table I . High performance liquid chromatography Alkylated DNA bases were separated by HPLC on a 5-um C 18 column (4.6X220 mm, Alltech Associates Inc. Deerfield, IL) eluted at 1 rruVmin. The Z.MatiJasevIc et al Studies with 3-methyladenine DNA glycosylase II 3-methyladenine DNA glycosylase II was purified from an over-producing strain of E.coli kindly provided by Professor Mutsuo Sekiguchi (18) . Purification was performed according to Nakabeppu et al. (18) through the DNAcellulose column step as described previously (14) . The purified enzyme migrated as a single band on a 12.5% polyacrylamide-0.1 % SDS gel at a molecular weight of 31 000. The enzyme was tested for nuclease activity against a double-stranded [ 3 H]thymidine DNA and the same DNA which contained apurinic sites. Negligible amounts of radioactivity were released into the ethanol-soluble fraction by the purified enzyme indicating that it was essentially free from non-specific nucleases. However, as a further precaution against nuclease activity, EDTA was added to incubations with [ Figure 1 were also performed at a six-fold scale (i.e. 132 |il); incubation was for 15 min at 37°C. The acid release data shown in the left-hand panel of that figure was normalized to the same scale.
Results
Figure 1 shows the distribution of alkylated bases in [
I4 C]SM-DNA and demonstrates the action of Gly II on this substrate. The distribution of adducts shown in the acid hydrolysate (lefthand panel) is similar to that which has been reported previously (4, 5) . The substrate used here contained, as a percentage of total alkylation, 7.7% HETEA, 63% HETEG and 19.5% crosslink (di-[2-guanin-7-yl-ethyl]sulfide). As shown in the righthand panel of this figure, a 15-min incubation at 37°C with Gly II released both HETEA and HETEG, but there was no evidence for release of the cross-link. There was very little spontaneous release (middle panel) of either modified base under these incubation conditions.
To establish the enzyme dependence of this release, and to compare the activity of Gly II towards SM-modified bases with its activity towards methylated bases, experiments were performed as shown in Figures 2 and 3 . Gly II releases both 3MA and 7MG readily from the methylated substrate as shown in the left-hand panel of Figure 2 . Although the amount of 7MG released is approximately one-third of the amount of 3MA released, the much greater activity of this enzyme towards 3MA than 7MG becomes apparent when these data are expressed as percentages. As shown in the right-hand panel of Figure 2 , -80% of the 3MA is released at the highest enzyme concentration, while only ~5% of the 7MG is released.
However, Gly II has a relatively much greater activity towards 7HETEG than 7MG as shown in Figure 3 . The lefthand panel of this figure shows that more 7HETEG than 3HETEA is released at each enzyme concentration-the reverse of what happens with a methylated substrate where more 3MA than 7MG is released. A comparison of the left-hand panel of Figure 2 with the left-hand panel of Figure 3 indicates that approximately twice as much 3MA as 3HETEA is released at each enzyme concentration, but more than three times as much 7HETEG as 7MG is released.
When the data in Figure 3 are expressed as a percentage of bases released, it is apparent that a higher percentage of 3HETEA is released than 7HETEG, but the preference of the enzyme for 3HETEA over 7HETEG is not as great as the preference for 3MA over 7MG. On a percentage basis, only about one-sixteenth as much 7MG is released as 3MA, but more than half as much 7HETEG is released as 3HETEA.
Time dependence experiments shown in Figures 4 and 5 lead to similar conclusions. Data for the methylated substrate are shown in Figure 4 ; the rapid release of 3MA in comparison with 7MG is apparent. For this substrate under these conditions, the initial rate of 3MA release is 0.087 pmol/min while the initial rate for 7MG is 0.01 pmol/min. Again, the difference is magnified when the data are expressed as percentages of bases present in the substrate.
For the hydroxyethylthioethyl bases, however, more 7HETEG is released than 3HETEA throughout the time course; for this particular substrate, the initial rate of 7HETEG release is 0.049 pmol/min while the initial rate of 3HETEA release is 0.011 pmol/min. Again, because there is approximately eight times as much 7HETEG as 3HETEA in the substrate (see Table I ), 7HETEG is released somewhat more slowly than 3HETEA on a percentage basis. However, in comparing the right-hand panel of Figure 5 with the right-hand panel of Figure 4 , the much greater activity of this enzyme towards 7HETEG than 7MG is again clearly illustrated.
Discussion
The ability of 3MA DNA glycosylase II (Gly II) to act on SM-modified DNA is perhaps not too surprising in view of its relatively broad substrate specificity. Gly II was originally characterized by its activity towards 3MA, but the early studies of Thomas et al. showed that Gly II could also release 3MA, 7MG, 7-methyladenine and carboxyethylated purines from DNA (19) . More recently, we have shown that Gly II acts upon a wide spectrum of chloroethylnitrosourea-modified bases (15, 20) . In addition to several 7-substituted guanines, Gly II releases the exocyclic adduct, N2,3-ethanoguanine, produced by the chloroethylnitrosoureas (21) . It also releases the related adduct, N2,3-ethenoguanine, which is introduced into DNA by metabolites of vinyl chloride (22) . Recently, Singer and co-workers have shown that human DNA glycosylase releases all four known exocyclic adducts formed in DNA by vinyl chloride metabolites (23) . Furthermore, Gly II releases the adducts, 3-ethylthioethyl- adenine and 7-ethylthioethylguanine, from DNA which has been modified by the one-armed SM CEES (14) . The results reported here are in close agreement with these earlier findings.
In both cases, SM-modified adenine is released somewhat more slowly than 3MA, while SM-modified guanine is released much more quickly than 7MG. It seems likely, therefore, that glycosylase activity is important in repairing DNA which has been modified by sulfur mustards and may well provide some protection against cytotoxicity. At the same time, the inability of Gly II to release the cross-link, di-(2-guanin-7-yl-ethyl)sulfide, is significant because the increased toxicity of bifunctional sulfur mustards in comparison with one-armed mustards has been attributed to their ability to form this cross-link (2). The results reported here do not eliminate the possibility that glycosylase acts to 'unhook' a cross-link in vivo as suggested by Reid and Walker (11), but other repair modalities including nucleotide excision and recombination repair probably act on the cross-link.
